CCND1 and lung carcinoma: Recently, Du et al. reported that miR-545 is downregulated in lung cancer compared with adjacent non-cancerous tissues and inhibits proliferation of lung cancer cells in vitro and in vivo by targeting cyclin D1 and CDK4 [11].